Extrait

• To assess safety and reactogenicity of 1 dose of 2830930A vaccine administered to toddlers aged 12-23 months primed with 3 doses of Synflorix, in terms of occurrence of grade 3 related solicited and unsolicited adverse events and related serious adverse events.

Critère d'inclusion

• 1-dose vaccination of healthy toddlers between 12-23 months of age at the time of vaccination against Streptococcus pneumoniae (S. pn) and Haemophilus influenzae (Hi) who previously received 3 doses of Synflorix

Liens

• euctr
• ictrp